CN1074665C - 诊断和/或治疗关节炎的药剂 - Google Patents

诊断和/或治疗关节炎的药剂 Download PDF

Info

Publication number
CN1074665C
CN1074665C CN94104956A CN94104956A CN1074665C CN 1074665 C CN1074665 C CN 1074665C CN 94104956 A CN94104956 A CN 94104956A CN 94104956 A CN94104956 A CN 94104956A CN 1074665 C CN1074665 C CN 1074665C
Authority
CN
China
Prior art keywords
chlorin
antibacterial
alanyl
amino
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN94104956A
Other languages
English (en)
Chinese (zh)
Other versions
CN1099613A (zh
Inventor
会泽胜夫
黑岩友佳力
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eneos Corp
Original Assignee
Nippon Petrochemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Petrochemicals Co Ltd filed Critical Nippon Petrochemicals Co Ltd
Publication of CN1099613A publication Critical patent/CN1099613A/zh
Application granted granted Critical
Publication of CN1074665C publication Critical patent/CN1074665C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036—Porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN94104956A 1993-04-22 1994-04-21 诊断和/或治疗关节炎的药剂 Expired - Lifetime CN1074665C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP120977/93 1993-04-22
JP120977/1993 1993-04-22
JP12097793A JP3565442B2 (ja) 1993-04-22 1993-04-22 哺乳類の関節炎の診断剤および／または治療剤

Publications (2)

Publication Number Publication Date
CN1099613A CN1099613A (zh) 1995-03-08
CN1074665C true CN1074665C (zh) 2001-11-14

Family

ID=14799730

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94104956A Expired - Lifetime CN1074665C (zh) 1993-04-22 1994-04-21 诊断和/或治疗关节炎的药剂

Country Status (7)

Country Link
US (2) US5430051A (enExample)
EP (1) EP0629409A1 (enExample)
JP (1) JP3565442B2 (enExample)
KR (1) KR100254135B1 (enExample)
CN (1) CN1074665C (enExample)
CA (1) CA2121716C (enExample)
TW (1) TW259706B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807881A (en) * 1992-05-27 1998-09-15 Quadra Logic Technologies, Inc. Method for selectively reducing activated leukocyte cell population
AU6031096A (en) * 1995-06-05 1996-12-24 Duke University Nitrosylated and nitrated superoxide oxidants and reductants
US5942534A (en) * 1996-10-10 1999-08-24 The General Hospital Corporation Photodynamic therapy for the treatment of osteoarthritis
US6350772B1 (en) * 1996-11-06 2002-02-26 Meiji Seika Kaisha, Ltd. Treatment of auto-immune diseases by photochemotherapy
US5952664A (en) * 1997-01-17 1999-09-14 Imaging Diagnostic Systems, Inc. Laser imaging apparatus using biomedical markers that bind to cancer cells
US20020173523A1 (en) * 1997-08-05 2002-11-21 Yukari Kuroiwa Immunosuppression by photochemotherapy
US6602274B1 (en) * 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
EP1131099A2 (en) * 1999-01-15 2001-09-12 Light Sciences Corporation Noninvasive vascular therapy
ATE234114T1 (de) * 1999-01-15 2003-03-15 Light Sciences Corp Therapeutische zusammensetzungen fur knochenstoffwechselstörungen oder knochenmetastasen enthaltend einen photosensitizer und ein bisphosphonat
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
CA2395567A1 (en) * 2000-01-12 2001-07-19 Light Sciences Corporation Novel treatment for eye disease
US7582670B2 (en) * 2001-12-13 2009-09-01 Natrogen Therapeutics, Inc. Methods of treating an inflammatory-related disease
US8563525B2 (en) 2004-01-12 2013-10-22 Natrogen Therapeutics International, Inc. Methods of treating an inflammatory-related disease
US20050154046A1 (en) * 2004-01-12 2005-07-14 Longgui Wang Methods of treating an inflammatory-related disease
AU2003248747A1 (en) 2002-06-27 2004-01-19 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
WO2004005289A2 (en) 2002-07-02 2004-01-15 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
CA2513133A1 (en) 2003-01-16 2004-07-29 Techno Mart Co., Ltd. Porphyrin derivatives
US10376711B2 (en) * 2003-03-14 2019-08-13 Light Sciences Oncology Inc. Light generating guide wire for intravascular use
CN2885311Y (zh) 2006-01-18 2007-04-04 郑成福 经尿道光动力疗法前列腺治疗仪
US20080269846A1 (en) * 2003-03-14 2008-10-30 Light Sciences Oncology, Inc. Device for treatment of blood vessels using light
US20080070971A1 (en) * 2006-03-06 2008-03-20 Wang Xiang H Medical Use of Bilirubin and its Structural Analogues
US8057464B2 (en) * 2006-05-03 2011-11-15 Light Sciences Oncology, Inc. Light transmission system for photoreactive therapy
WO2008005308A2 (en) 2006-06-30 2008-01-10 Light Sciences Oncology, Inc. Compositions and methods of making a chlorin e6 derivative as a photoactive agent
BRPI0815175B8 (pt) * 2007-08-14 2021-06-22 Mivenion Gmbh dispositivo para um diagnóstico e/ou monitoramento de terapia de doenças inflamatórias tal como artrite reumatoide
CN101426268B (zh) * 2007-11-02 2010-08-25 大唐移动通信设备有限公司 导频资源分配方法、系统和设备
CN101861143B (zh) * 2007-11-15 2015-09-09 拜莱泰克制药市场有限公司 用于炎性疾病的光动力治疗的聚乙二醇化脂质体制剂
CN107987081B (zh) * 2016-10-26 2019-12-06 刘辉 一种二氢卟吩e6衍生物及其药学上可接受的盐、其制备方法和应用
US20230330138A1 (en) * 2022-04-14 2023-10-19 Creative Medical Technologies, Inc. Treatment of cartilage degeneration using myeloid suppressor cells and exosomes derived thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028594A (en) * 1988-12-27 1991-07-02 Naxcor Use of photodynamic compositions for cytotoxic effects

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3102891A (en) * 1959-11-16 1963-09-03 Elmer A Allen New porphyrinic and chlorophyllic compositions and process therefor
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US5066274A (en) * 1985-04-30 1991-11-19 Nippon Petrochemicals Company, Ltd. Tetrapyrrole therapeutic agents
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
US5004811A (en) * 1987-12-24 1991-04-02 Nippon Petrochemicals Company, Ltd. Tetrapyrrole aminocarboxylic acids
US4997639A (en) * 1989-11-27 1991-03-05 Nippon Petrochemicals Company, Limited Method for detecting cholesterol deposited in bodies of mammals
JP3154742B2 (ja) * 1991-04-30 2001-04-09 日本石油化学株式会社 哺乳類の動脈硬化症治療剤
PL172480B1 (pl) * 1992-11-20 1997-09-30 Univ British Columbia Kompozycja do niszczenia lub uszkadzania obszaru nowego unaczynienia PL PL
US5368841A (en) * 1993-02-11 1994-11-29 The General Hospital Corporation Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028594A (en) * 1988-12-27 1991-07-02 Naxcor Use of photodynamic compositions for cytotoxic effects

Also Published As

Publication number Publication date
JP3565442B2 (ja) 2004-09-15
KR100254135B1 (ko) 2000-05-01
US5567409A (en) 1996-10-22
TW259706B (enExample) 1995-10-11
CA2121716A1 (en) 1994-10-23
CN1099613A (zh) 1995-03-08
US5430051A (en) 1995-07-04
EP0629409A1 (en) 1994-12-21
CA2121716C (en) 2008-01-08
JPH06305961A (ja) 1994-11-01

Similar Documents

Publication Publication Date Title
CN1099613A (zh) 诊断和/或治疗关节炎的方法与药剂
CN1057095C (zh) 新型肽,其制备及应用
CN1166597C (zh) 含氮基团的转化方法
CN1098274C (zh) 氮杂环己肽化合物
CN1298703C (zh) 氰基吡咯烷衍生物
CN1163267C (zh) Glp-1或类似物在中风中的用途
CN1158305C (zh) 增强了锌结合力的胰岛素衍生物
CN1268636C (zh) 多拉司他汀15衍生物
CN1832959A (zh) 聚乙二醇连接的glp－1化合物
CN1156964A (zh) 新肽
CN1930190A (zh) 透明质酸衍生物及含有其的药剂
CN1649625A (zh) 治疗剂或细胞毒性剂与生物活性肽的偶联物
CN1505617A (zh) 作为Met-AP2抑制剂的肽
CN1121806A (zh) 用于治疗呕吐的药剂
CN1454214A (zh) 具有增高功效的修饰生物肽
CN1300222A (zh) 策略性修饰的乙肝核心蛋白及其衍生物
CN1160069C (zh) 钯取代的细菌叶绿素衍生物及其应用
CN1918131A (zh) 新的谷氨酰胺酰基环化酶抑制剂
CN1791401A (zh) 用于生产二肽基肽酶iv抑制剂和它的中间体的方法和化合物
CN1714091A (zh) 中位取代卟啉
CN1494425A (zh) 用作治疗剂的羧酰胺衍生物
CN1150176C (zh) 芳烷酮哌嗪衍生物及其应用
CN1284086A (zh) 可用于治疗前列腺癌的缀合物
CN101048139A (zh) 药物活性化合物的控释组合物
CN1150028C (zh) 三-、四-、五-和多肽以及它们作为抗抑郁剂的治疗应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: SHIN NIHON OIL CO., LTD.

Free format text: FORMER OWNER: NIPPON PETROCHEMICALS COMPANY, LIMITED

Effective date: 20070330

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20070330

Address after: Tokyo, Japan

Patentee after: Nippon Oil Corporation

Address before: Tokyo, Japan, Japan

Patentee before: Nippon Petrochemicals Co., Ltd.

C17 Cessation of patent right
CX01 Expiry of patent term

Expiration termination date: 20140421

Granted publication date: 20011114